Literature DB >> 7648288

Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.

L A Valleroy1, B Weinstein, T S Jones, S L Groseclose, R T Rolfs, W J Kassler.   

Abstract

In May 1992, the Connecticut legislature passed new laws aimed at increasing injecting drug users' (IDUs) access to sterile needles and syringes (syringes); as of July 1992, pharmacists were permitted to sell and individuals were permitted to possess up to 10 syringes without medical prescriptions (nonprescription syringes). We evaluated the impact of the new laws by conducting (1) prospective surveillance of syringe sales and policies at selected community pharmacies (pharmacies) and (2) a telephone survey of pharmacy managers' reports of syringe sales and policies at a statewide stratified random sample of pharmacies. Our data provide direct evidence that most, but not all, Connecticut pharmacies sold nonprescription syringes when permitted to do so by the new laws. For example, using the telephone survey data, we estimate that during November, 1993, 83% [95% CI: 77-89%] of all Connecticut pharmacies sold nonprescription syringes and 56,000 [95% CI: 44,000-68,000] nonprescription syringes were sold, during November 1993. Our data provide indirect evidence that IDUs were purchasing nonprescription syringes at pharmacies. For example, in five Hartford pharmacies located in neighborhoods where injection drug use was prevalent, the total number of nonprescription syringes sold per month increased significantly from 460 in July 1992 to 2,482 in June 1993 (p = 0.0001). The data suggest that the new laws increased IDUs' access to sterile syringes in Connecticut.

Mesh:

Year:  1995        PMID: 7648288

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  13 in total

1.  Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices.

Authors:  C R Harbke; D G Fisher; H H Cagle; B N Trubatch; A M Fenaughty; M E Johnson
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

2.  Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission.

Authors:  S J Klein; G S Birkhead; A R Candelas
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

3.  Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.

Authors:  Valerie J Rose; Glenn Backes; Alexis Martinez; Willi McFarland
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

4.  Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California.

Authors:  Alex H Kral; Richard S Garfein
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

5.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

6.  Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.

Authors:  Hannah L F Cooper; Brian H Bossak; Barbara Tempalski; Samuel R Friedman; Don C Des Jarlais
Journal:  J Urban Health       Date:  2009-11       Impact factor: 3.671

7.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

8.  Factors associated with presence of pharmacies and pharmacies that sell syringes over-the-counter in Los Angeles County.

Authors:  Thomas J Stopka; Estella M Geraghty; Rahman Azari; Ellen B Gold; Kathryn Deriemer
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

9.  Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.

Authors:  M Singer; H A Baer; G Scott; S Horowitz; B Weinstein
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

Review 10.  The role of needle exchange programs in HIV prevention.

Authors:  D Vlahov; B Junge
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.